Analyst Ratings for aTyr Pharma (LIFE) [Neutrals]
LIFE Rating Summary
LIFE Price Target Summary
- Highest: $20.00 (Piper Sandler)
- Lowest: $16.00 (RBC Capital)
- Average: $18.00
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$18.00 (+818.4%)
* Over Last 12-Mos
Rating Score: 5.5 / 10 Percentile Rank: 59%
Rating Score: 5.5 / 10 Percentile Rank: 59%
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
7/5/2023 | Oppenheimer | Hartaj Singh | Downgrade | Perform (Outperform) |
N/A (N/A) |
2.23 (1.96) |
-12.11% | Details |
8/17/2018 | Citi » Updated 8/30/2019 |
Joel Beatty | Upgrade | Neutral (Sell) |
3.75 (7.00) |
0.63 (1.96) |
211.11% | Details |